Dr. Anolik is a Professor of Medicine and Division Chief of the Division of Allergy, Immunology, Rheumatology and Director of the ABIM Physician Scientist Training Program. She is a board-certified rheumatologist with a special research interest in lupus, rheumatoid arthritis, and other systemic autoimmune diseases. Her lab focuses on the role of B cells in human autoimmune disease and was part of the first group to investigate the use of rituximab in the treatment of lupus and the effects of B cell depletion on immune function in lupus and rheumatoid arthritis patients (https://www.urmc.rochester.edu/medicine/airresearch/translational-resea…). She has published extensively in the area of B cell biology, is a member of the American Society of Clinical Investigation, and PI of an NIH Accelerating Medicines Partnership Network grant (https://www.niams.nih.gov/newsroom/press-releases/nih-program-accelerat…).